These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 821310)

  • 21. Sequential metabolism of sesamin by cytochrome P450 and UDP-glucuronosyltransferase in human liver.
    Yasuda K; Ikushiro S; Kamakura M; Munetsuna E; Ohta M; Sakaki T
    Drug Metab Dispos; 2011 Sep; 39(9):1538-45. PubMed ID: 21622626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of repeated administration of 11-hydroxy-delta 8-tetrahydrocannabinol, an active metabolite of delta 8-tetrahydrocannabinol, on the hepatic microsomal drug-metabolizing enzyme system of mice.
    Watanabe K; Arai M; Narimatsu S; Yamamoto I; Yoshimura H
    Biochem Pharmacol; 1986 Jun; 35(11):1861-5. PubMed ID: 3013200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of curcumin, capsaicin, and piperine on the rat liver drug-metabolizing enzyme system in vivo and in vitro.
    Suresh D; Srinivasan K
    Can J Physiol Pharmacol; 2006 Dec; 84(12):1259-65. PubMed ID: 17487234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction with drugs and environmental chemicals. Effects of ascorbic acid on microsomal drug metabolism.
    Zannoni VG; Sato PH
    Ann N Y Acad Sci; 1975 Sep; 258():119-31. PubMed ID: 1060396
    [No Abstract]   [Full Text] [Related]  

  • 25. The obligatory requirement of cytochrome b5 in the p-nitroanisole O-demethylation reaction catalyzed by cytochrome P-450 with a high affinity for cytochrome b5.
    Sugiyama T; Miki N; Yamano T
    Biochem Biophys Res Commun; 1979 Oct; 90(3):715-20. PubMed ID: 508337
    [No Abstract]   [Full Text] [Related]  

  • 26. UDP glucuronosyltransferase and mixed function oxidase activity in microsomes prepared by differential centrifugation and calcium aggregation.
    Aitio A; Vainio H
    Acta Pharmacol Toxicol (Copenh); 1976; 39(5):555-61. PubMed ID: 824931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of vitamin A deficiency on pulmonary and hepatic in vitro metabolism of benzo(a)pyrene in rat.
    Dogra SC; Khanduja KL; Sharma RR; Hom T; Varanasi U
    Biochem Int; 1985 Dec; 11(6):869-84. PubMed ID: 3937530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The involvement of cytochrome P-450 in the NADH-dependent O-demethylation of p-nitroanisole in phenobarbital-treated rabbit liver microsomes.
    Kamataki T; Kitagawa H
    Biochem Biophys Res Commun; 1977 Jun; 76(4):1007-13. PubMed ID: 20083
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatic cytochrome P-450 and in vitro drug metabolism in an overfed rat model of obesity.
    Matsumoto RM; Jusko WJ; Corcoran GB
    Drug Nutr Interact; 1988; 5(4):236-47. PubMed ID: 3149237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in the drug-metabolizing enzyme activities among fish and bivalves living in waters near industrial and non-industrial areas.
    Oshima Y; Kobayashi K; Hidaka C; Izu S; Imada N
    Bull Environ Contam Toxicol; 1994 Jul; 53(1):106-12. PubMed ID: 8069058
    [No Abstract]   [Full Text] [Related]  

  • 31. Diphasic action of the aliphatic amide, HOE 17879, on hepatic microsomal drug metabolizing enzymes in the mouse.
    Beyhl FE; Lindner E
    Experientia; 1976 Mar; 32(3):362-5. PubMed ID: 176059
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of 18 alpha-glycyrrhizic acid on rat liver cytochrome P450 isoenzymes and phase II transferase].
    Yang J; Peng RX; Kong R; Yu JP
    Yao Xue Xue Bao; 2001 May; 36(5):321-4. PubMed ID: 12584850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibody characterization of hepatic and extrahepatic cytochrome P-450 activities in rats treated with phenobarbital or methylcholanthrene and fed various cholesterol diets.
    Hietanen E; Ahotupa M; Béréziat JC; Park SS; Gelboin HV; Bartsch H
    Biochem Pharmacol; 1987 Nov; 36(22):3973-80. PubMed ID: 3500724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ascorbic acid and hepatic drug metabolism.
    Sato PH; Zannoni VG
    J Pharmacol Exp Ther; 1976 Aug; 198(2):295-307. PubMed ID: 948027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociation of microsomal ethanol oxidation from cytochrome P-450 catalyzed drug metabolism.
    Vatsis KP; Schulman MP
    Adv Exp Med Biol; 1975; 58(00):369-82. PubMed ID: 239541
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanism of inhibition of microsomal drug metabolism by imidazole.
    Hajek KK; Cook NI; Novak RF
    J Pharmacol Exp Ther; 1982 Oct; 223(1):97-104. PubMed ID: 7120133
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of liver warm ischemia on the hepatic microsomal cytochrome P-450 monooxygenase system.
    Izuishi K; Hamamoto I; Ichikawa Y; Okano K; Akram HM; Maeba T; Tanaka S
    Transplant Proc; 1994 Aug; 26(4):2417-9. PubMed ID: 8066792
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterization of the hepatic microsomal mixed-function oxidase enzyme system in miniature pigs.
    Freudenthal RI; Leber P; Emmerling D; Kerchner G; Campbell D
    Drug Metab Dispos; 1976; 4(1):25-7. PubMed ID: 3397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of phenylmercuric acetate on the activity of aniline 4-hydroxylase and P-nitroanisole O-demethylase in the rat liver].
    Sciezyńska H; Urbanek-Karłowska B
    Rocz Panstw Zakl Hig; 1980; 31(1):73-7. PubMed ID: 7384692
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of a tyrosine-divalent copper complex on hepatic microsomal demethylation.
    Richter C; Azzi A; Wendel A
    FEBS Lett; 1976 May; 64(2):332-7. PubMed ID: 179884
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.